Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Liew

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
The Lancet. Rheumatology|July 6, 2024
Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient careLaura E Eades, Alberta Y Hoi, Ruaidhri Liddle, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Rheumatology (Oxford, England)|November 10, 2017
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumaticaClaire E Owen, Aurora M T Poon, Sze Ting Lee, et al.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
Tropical Biomedicine|November 16, 2024
Antibiotic use in a co-infection of respiratory syncytial virus and pathogenic bacteria in children in a resource-limited setting in northeast Peninsular MalaysiaC S L Liew, R M Guad, A W Taylor-Robinson, et al.
The Lancet. Rheumatology|July 28, 2021
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseasesJonathan S Hausmann, Kevin Kennedy, Julia F Simard, et al.
The Journal of Rheumatology|June 1, 2025
Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in AdultsMaria B Sukkar, Rosemary Ainley, Claire Barrett, et al.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Australasian Journal on Ageing|February 26, 2026
Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi StudyAmanda J Cross, Madiha Chaudhry, Darshna Goordeen, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
The Lancet. Rheumatology|July 6, 2024
Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient careLaura E Eades, Alberta Y Hoi, Ruaidhri Liddle, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Rheumatology (Oxford, England)|November 10, 2017
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumaticaClaire E Owen, Aurora M T Poon, Sze Ting Lee, et al.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
Tropical Biomedicine|November 16, 2024
Antibiotic use in a co-infection of respiratory syncytial virus and pathogenic bacteria in children in a resource-limited setting in northeast Peninsular MalaysiaC S L Liew, R M Guad, A W Taylor-Robinson, et al.
The Lancet. Rheumatology|July 28, 2021
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseasesJonathan S Hausmann, Kevin Kennedy, Julia F Simard, et al.
The Journal of Rheumatology|June 1, 2025
Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in AdultsMaria B Sukkar, Rosemary Ainley, Claire Barrett, et al.
ESMO Open|January 21, 2026
Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancerE J van Dijk, M M Smeenk, F Bensch, et al.
Australasian Journal on Ageing|February 26, 2026
Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi StudyAmanda J Cross, Madiha Chaudhry, Darshna Goordeen, et al.
Pageof 10